Liberty Health Sciences is Honored to Announce Strategic Partnership with the Veterans Cannabis Project
- Company to Honor Veterans by Increasing Access to Cannabis Products -
TORONTO, July 3, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) ("Liberty" or the "Company") is honored to announce its partnership with the Veterans Cannabis Project, an association dedicated to improving US military veterans' quality of life through the opportunity of cannabis.
To better provide effective treatment options for those who are serving, and have served, our country in the armed forces, Liberty is collaborating with Veterans Cannabis Project to support vital research projects focused on the treatment of service related trauma with cannabis derived products. In an effort to launch this important alliance and demonstrate the Company's commitment to, and admiration for, veterans nationwide, Liberty will offer a 25% discount on all purchases for armed forces personnel.
"Liberty is proud to provide support to these brave individuals through the development of state and national programs and these essential research initiatives," said George Scorsis, CEO Liberty Health Sciences. "Those who have answered the call to duty deserve no less than the very best treatment options and Liberty is privileged to serve those who have sacrificed so much for their country."
"The Veterans Cannabis Project is excited to have partnered with Liberty Health Sciences to advance veterans' access to life saving medicine, and to also tackle critical research initiatives" said Nick Etten, Executive Director of the Veterans Cannabis Project. "And we are also thankful for Liberty's support of our federal-level advocacy efforts, which includes sponsoring veterans traveling to Washington, DC, to meet with their lawmakers on this important issue."
To further celebrate servicemembers and the week of Independence Day, the Company is offering a limited supply of vaporizer products. Vaporizers are available in 250 mg Indica disposables and 500 mg Indica cartridge with battery. A portion of the proceeds will be donated to support Veterans Cannabis Project. The vaporizers will be available in stores on July 1st.
About Veterans Cannabis Project
Veterans Cannabis Project is a nonprofit organization working to improve US military veterans' quality of life through the opportunity of cannabis. The organization is dedicated to educating lawmakers and veterans about the meaningful health benefits of cannabis.
About Liberty Health Sciences Inc.
Liberty Health Sciences Inc. operates in cannabis markets focusing on improving the lives of our consumers. Liberty's stringent investment criteria for expansion maximizes returns to shareholders, while focusing on significant near- and mid-term opportunities while keeping consumers' well-being at the forefront of what we do. Liberty has an extensive background in highly regulated industries, with expertise in becoming a low-cost producer. Liberty leverages commercial greenhouse knowledge to deliver high-quality, clean and safe pharmaceutical grade cannabis to consumers.
For more information, please visit libertyhealthsciences.com
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains certain forward-looking statements within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "believe", "plan", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the production and sale of edible products in Florida, expected state approval of edibles, and the Company's future expansion and growth strategies. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Liberty Health Sciences Inc.
For Canadian media inquiries, please contact: Hilary Sloan, Edelman, (416) 908-2134, [email protected]; For U.S. media inquiries, please contact: David Schull or Nic Johnson, Russo Partners, (858) 717-2310, [email protected], [email protected]
Share this article